Liver biopsies from NAFLD patients show increased activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome and nuclear factor-kappa B (NF-κB) pathways, correlating with disease severity [42]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.